[1] CHEN W,ZHENG R,BAADE P D,et al.Cancer statistics in China,2015[J].CA:a Cancer Journal for Clinicians,2016,66(2):115-132.
[2] 李道娟,李倩,贺宇彤.结直肠癌流行病学趋势[J].肿瘤防治研究,2015(3):305-310.
[3] CLARKE E,WOOLSON K,SAUNDERS M,et al.PWE-100 missed rates of colorectal cancer-diagnostic limitations[J].Gut,2016,65(Suppl 1):A187-A188.
[4] BAILEY J R,AGGARWAL A,IMPERIALE T F.Colorectal cancer screening:stool DNA and other noninvasive modalities[J].Gut and Liver,2016,10(2):204.
[5] EASWARAN H,TSAI H C,BAYLIN S B.Cancer epigenetics:tumor heterogeneity,plasticity of stem-like states,and drug resistance[J].Molecular Cell,2014,54(5):716-727.
[6] 剧宏燕,柴秀坤,白文元.结直肠癌的表观遗传学[J].世界华人消化杂志,2014,22(15):2128-2133.
[7] 李莉,鲁英,杨晓燕,等.新疆乳腺癌患者外周血中p16基因甲基化的检测意义[J].东南大学学报:医学版,2014,33(6):691-696.
[8] 邹继红,吴平平,汤日宁,等.结直肠癌血清中DLC1,p16和RUNX3基因甲基化检测的临床意义[J].江苏医药,2011,37(24):2938-2940.
[9] 王裴,张明鑫,张超,等.粪便DNA甲基化检测在结直肠癌早期诊断中的研究进展[J].现代肿瘤医学,2015,23(6):874-880.
[10] 周婷婷,丁家华.异基因造血干细胞移植治疗骨髓增生异常综合征的时机选择[J].现代医学,2013,41(4):279-281.
[11] JENSEN E.Laser-capture microdissection[J].The Anatomical Record,2013,296(11):1683-1687.
[12] TESCHENDORFF A E,MARABITA F,LECHNER M,et al.A beta-mixture quantile normalization method for correcting probe design bias in illumina infinium 450 k DNA methylation data[J].Bioinformatics,2013,29(2):189-196.
[13] MU W,WANG J,NIU Q,et al.Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer:a meta-analysis[J].OncoTargets and Therapy,2014,7:1237-1245. |